VWF and transient ischemic attack: As the main ligand of the GPIb receptor, VWF is differentially regulated in patients with acute ischemic stroke (AIS)/transient ischemic attack (TIA) and chronic cerebrovascular diseases (CCD), as well as in healthy volunteers (HV) [11], whereas the regulation of GPIb and GPIIb/IIIa receptors has not yet been assessed in detail.